Literature DB >> 10498603

PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.

K L Anderson1, K A Smith, H Perkin, G Hermanson, C G Anderson, D J Jolly, R A Maki, B E Torbett.   

Abstract

PU.1 is a hematopoietic cell-specific ets family transcription factor. Gene disruption of PU.1 results in a cell autonomous defect in hematopoietic progenitor cells that manifests as abnormal myeloid and B-lymphoid development. Of the myeloid lineages, no mature macrophages develop, and the neutrophils that develop are aberrantly and incompletely matured. One of the documented abnormalities of PU. 1 null (deficient) hematopoietic cells is a failure to express receptors for granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage (GM)-CSF, and M-CSF. To elucidate the roles of the myeloid growth factor receptors in myeloid cell differentiation, and to distinguish their role from that of PU.1, we have restored expression of the G- and M-CSF receptors in PU.1-deficient cells using retroviral vectors. We have similarly expressed PU.1 in these cells. Whereas expression of growth factor receptors merely allows a PU.1-deficient cell line to survive and grow in the relevant growth factor, expression of PU.1 enables the development of F4/80(+), Mac-1(+)/CD11b(+) macrophages, expression of gp91(phox) and generation of superoxide, and expression of secondary granule genes for neutrophil collagenase and gelatinase. These studies reinforce the idea that availability of PU.1 is crucial for normal myeloid development and clarify some of the molecular events in developing neutrophils and macrophages that are critically dependent on PU.1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498603

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia.

Authors:  Manjula Karpurapu; Xuerong Wang; Jing Deng; Hyesuk Park; Lei Xiao; Ruxana T Sadikot; Randall S Frey; Ulrich A Maus; Gye Young Park; Edward W Scott; John W Christman
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.

Authors:  Christine Yeamans; Dehua Wang; Ido Paz-Priel; Bruce E Torbett; Daniel G Tenen; Alan D Friedman
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

3.  Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1.

Authors:  Athanasia D Panopoulos; David Bartos; Ling Zhang; Stephanie S Watowich
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

4.  Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPepsilon gene.

Authors:  Arati Khanna-Gupta; Hong Sun; Theresa Zibello; Han Myung Lee; Richard Dahl; Laurence A Boxer; Nancy Berliner
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

5.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.

Authors:  K R Calvo; D B Sykes; M Pasillas; M P Kamps
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation.

Authors:  Mark W Feinberg; Akm Khyrul Wara; Zhuoxiao Cao; Maria A Lebedeva; Frank Rosenbauer; Hiromi Iwasaki; Hideyo Hirai; Jonathan P Katz; Richard L Haspel; Susan Gray; Koichi Akashi; Julie Segre; Klaus H Kaestner; Daniel G Tenen; Mukesh K Jain
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

8.  Rapid and quantitative detection of p38 kinase pathway in mouse blood monocyte.

Authors:  Jingyong Zhao; Glenn Evans; Weiming Li; Lisa Green; Shaoyou Chu; Phil Marder; Songqing Na
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-04-09       Impact factor: 2.416

9.  The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Authors:  Trevor P Fidler; Chenyi Xue; Mustafa Yalcinkaya; Brian Hardaway; Sandra Abramowicz; Tong Xiao; Wenli Liu; David G Thomas; Mohammad Ali Hajebrahimi; Joachim Pircher; Carlos Silvestre-Roig; Andriana G Kotini; Larry L Luchsinger; Ying Wei; Marit Westerterp; Hans-Willem Snoeck; Eirini P Papapetrou; Christian Schulz; Steffen Massberg; Oliver Soehnlein; Benjamin Ebert; Ross L Levine; Muredach P Reilly; Peter Libby; Nan Wang; Alan R Tall
Journal:  Nature       Date:  2021-03-17       Impact factor: 69.504

10.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.

Authors:  Aleksandar Dakic; Donald Metcalf; Ladina Di Rago; Sandra Mifsud; Li Wu; Stephen L Nutt
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.